Compare Stocks

Date Range: 

 Travere TherapeuticsImmunoGenPrelude TherapeuticsDiaMedica TherapeuticsuniQure
SymbolNASDAQ:TVTXNASDAQ:IMGNNASDAQ:PRLDOTCMKTS:DMCAFNASDAQ:QURE
Price Information
Current Price$20.01$7.33$41.61$0.38$32.55
52 Week RangeBuyBuyHoldN/ABuy
MarketRank™
Overall Score1.31.51.60.41.7
Analysis Score3.53.33.20.03.5
Community Score2.82.42.52.12.9
Dividend Score0.00.00.00.00.0
Ownership Score0.01.71.70.01.7
Earnings & Valuation Score0.00.00.60.00.6
Analyst Ratings
Consensus RecommendationBuyBuyHoldN/ABuy
Consensus Price Target$42.67$10.10$55.80N/A$68.46
% Upside from Price Target113.23% upside37.79% upside34.10% upsideN/A110.33% upside
Trade Information
Market Cap$1.21 billion$1.47 billion$1.48 billion$1.34 billion$1.49 billion
Beta0.771.65N/A-0.021.19
Average Volume579,0602,258,677222,638131,151469,884
Sales & Book Value
Annual Revenue$175.34 million$82.27 millionN/AN/A$7.28 million
Price / Sales6.9017.81N/AN/A205.34
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$5.15 per share($0.51) per shareN/AN/A$7.41 per share
Price / Book3.89-14.37N/AN/A4.39
Profitability
Net Income$-146,430,000.00$-104,130,000.00N/A$-2,220,000.00$-124,200,000.00
EPS($3.46)($0.70)N/AN/A($3.11)
Trailing P/E RatioN/AN/A0.000.00N/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-40.24%-77.65%N/AN/A-2,738.33%
Return on Equity (ROE)-29.27%N/AN/AN/A-59.64%
Return on Assets (ROA)-12.25%-26.98%N/AN/A-41.47%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.71%N/AN/AN/A0.16%
Current Ratio6.60%2.20%20.96%N/A8.62%
Quick Ratio6.50%2.20%20.96%N/A8.62%
Ownership Information
Institutional Ownership PercentageN/A72.95%76.21%N/A78.34%
Insider Ownership Percentage4.63%3.77%N/AN/A2.79%
Miscellaneous
EmployeesN/A7968N/A332
Shares Outstanding60.44 million199.94 million35.50 million157.14 million45.93 million
Next Earnings Date7/29/2021 (Estimated)5/10/2021 (Confirmed)6/15/2021 (Estimated)N/A5/12/2021 (Estimated)
OptionableOptionableOptionableNot OptionableNot OptionableOptionable
SourceHeadline
How To Experience The Unique Cultures Of African Tribes - TravelAwaitsHow To Experience The Unique Cultures Of African Tribes - TravelAwaits
travelawaits.com - May 9 at 10:34 PM
Brothers had unique view of 2016 World Series champs - Daily HeraldBrothers had unique view of 2016 World Series champs - Daily Herald
dailyherald.com - May 9 at 10:34 PM
Local business offers a unique way to relieve stress — with goats - WIVB.com - News 4Local business offers a unique way to relieve stress — with goats - WIVB.com - News 4
wivb.com - May 9 at 10:34 PM
Mother’s Day: Maine mom forms unique bond with gorilla at Boston zoo - KIRO SeattleMother’s Day: Maine mom forms unique bond with gorilla at Boston zoo - KIRO Seattle
kiro7.com - May 9 at 10:34 PM
Two classes graduate in unique PSU ceremony | Education | unionleader.com - The Union LeaderTwo classes graduate in unique PSU ceremony | Education | unionleader.com - The Union Leader
unionleader.com - May 9 at 10:34 PM
PTAB Declines To Enter Adverse Judgment Against Pre-Institution Disclaimed Claims - JD SupraPTAB Declines To Enter Adverse Judgment Against Pre-Institution Disclaimed Claims - JD Supra
jdsupra.com - May 8 at 3:15 PM
Novel Coronavirus Unique Infectious Profile Makes COVID-19 Difficult to Treat: Lancet | The Weather Channel - Articles from The Weather Channel | weather.com - The Weather ChannelNovel Coronavirus' Unique Infectious Profile Makes COVID-19 Difficult to Treat: Lancet | The Weather Channel - Articles from The Weather Channel | weather.com - The Weather Channel
weather.com - May 8 at 8:51 AM
Unique-looking bird is one of many animals born during baby boom at San Antonio Zoo - KSAT San AntonioUnique-looking bird is one of many animals born during baby boom at San Antonio Zoo - KSAT San Antonio
ksat.com - May 8 at 8:51 AM
When theatres went dark, stagehands struggled to keep their unique community strong - KUOW News and InformationWhen theatres went dark, stagehands struggled to keep their unique community strong - KUOW News and Information
kuow.org - May 8 at 8:51 AM
Unique New Accommodations on Jamaicas South Coast - TravelPulseUnique New Accommodations on Jamaica's South Coast - TravelPulse
travelpulse.com - May 8 at 12:23 AM
SLC veterans home welcomes unique comfort animal - fox13now.comSLC veterans home welcomes unique comfort animal - fox13now.com
fox13now.com - May 8 at 12:23 AM
Columbus Woman Has Unique Journey To Motherhood - WCBIColumbus Woman Has Unique Journey To Motherhood - WCBI
wcbi.com - May 8 at 12:23 AM
NSFs unique R&D effort aims to solve societal challenges - Federal News NetworkNSF's unique R&D effort aims to solve societal challenges - Federal News Network
federalnewsnetwork.com - May 7 at 7:23 PM
Texas treehouse rentals can be unique vacation experience - KSAT San AntonioTexas treehouse rentals can be unique vacation experience - KSAT San Antonio
ksat.com - May 7 at 2:21 PM
Unique and unusual for middle school shooter to be female, says former deputy chief - KUTV 2News'Unique and unusual' for middle school shooter to be female, says former deputy chief - KUTV 2News
kutv.com - May 7 at 2:21 PM
A Small Brazilian Town Is Beating Covid-19 Through a Unique Experiment - The Wall Street JournalA Small Brazilian Town Is Beating Covid-19 Through a Unique Experiment - The Wall Street Journal
wsj.com - May 7 at 2:21 PM
Buy Or Fear uniQure NV Stock: QUREs 48% Decline In A Year Despite Revenues Increasing 415% YoY Over The Last 4 Quarters Looks Like A Buying Opportunity. The stock has gained 68% since the end of 2017 due to favorable Changes In Its Total Revenues - TrefisBuy Or Fear uniQure NV Stock: QURE's 48% Decline In A Year Despite Revenues Increasing 415% YoY Over The Last 4 Quarters Looks Like A Buying Opportunity. The stock has gained 68% since the end of 2017 due to favorable Changes In Its Total Revenues - Trefis
dashboards.trefis.com - May 7 at 9:21 AM
Bees thrive where its hot and dry: A unique biodiversity hotspot located in North America - Science DailyBees thrive where it's hot and dry: A unique biodiversity hotspot located in North America - Science Daily
sciencedaily.com - May 7 at 4:18 AM
Breweries and botanists have partnered for a unique fundraiser in Verona - TribLIVEBreweries and botanists have partnered for a unique fundraiser in Verona - TribLIVE
triblive.com - May 7 at 4:18 AM
Unique and unusual for middle school shooter to be female, says former deputy chief - KJZZ'Unique and unusual' for middle school shooter to be female, says former deputy chief - KJZZ
kjzz.com - May 7 at 4:18 AM
Apple has a whitelist of developers who can access unique App Store features - AppleInsiderApple has a 'whitelist' of developers who can access unique App Store features - AppleInsider
appleinsider.com - May 6 at 11:18 PM
Unusual semimetal shows evidence of unique surface conduction states - EurekAlertUnusual semimetal shows evidence of unique surface conduction states - EurekAlert
eurekalert.org - May 6 at 6:17 PM
Unique Logistics Adds 52 New Cargo Charter Flights from Asia to the United States - PRNewswireUnique Logistics Adds 52 New Cargo Charter Flights from Asia to the United States - PRNewswire
prnewswire.com - May 6 at 6:17 PM
Drive-thru and jazz band. A unique graduation in - Bay News 9Drive-thru and jazz band. A unique graduation in - Bay News 9
baynews9.com - May 6 at 6:17 PM
Why Moderna, uniQure And Novavax Are Moving Today - BenzingaWhy Moderna, uniQure And Novavax Are Moving Today - Benzinga
benzinga.com - May 6 at 6:17 PM
DateCompanyBrokerageAction
5/7/2021Travere TherapeuticsBMO Capital MarketsLower Price Target
4/12/2021Travere TherapeuticsWedbushLower Price Target
3/3/2021Travere TherapeuticsSVB LeerinkReiterated Rating
2/3/2021Travere TherapeuticsCanaccord GenuityBoost Price Target
11/23/2020Travere TherapeuticsEvercore ISIInitiated Coverage
2/16/2021ImmunoGenHC WainwrightBoost Price Target
12/7/2020ImmunoGenPiper SandlerBoost Price Target
10/2/2020ImmunoGenGuggenheimUpgrade
9/29/2020ImmunoGenJPMorgan Chase & Co.Initiated Coverage
9/18/2020ImmunoGenWilliam BlairReiterated Rating
12/10/2019ImmunoGenCowenReiterated Rating
3/23/2021Prelude TherapeuticsMorgan StanleyBoost Price Target
3/9/2021Prelude TherapeuticsBarclaysInitiated Coverage
11/20/2020Prelude TherapeuticsBank of AmericaDowngrade
10/20/2020Prelude TherapeuticsThe Goldman Sachs GroupInitiated Coverage
4/1/2021uniQureMizuhoUpgrade
3/8/2021uniQureChardan CapitalBoost Price Target
12/22/2020uniQureRoyal Bank of CanadaBoost Price Target
12/9/2020uniQureJefferies Financial GroupBoost Price Target
11/20/2020uniQureCredit Suisse GroupBoost Price Target
11/11/2020uniQureBerenberg BankInitiated Coverage
11/4/2020uniQureCantor FitzgeraldInitiated Coverage
8/24/2020uniQureRaymond JamesInitiated Coverage
7/31/2020uniQureRobert W. BairdUpgrade
6/25/2020uniQureStifel NicolausLower Price Target
(Data available from 5/10/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.